
MDXXF
Healthcare · Biotechnology · $10.5M market cap
$0.0951-0.01 (-7.1%)Nov 13, 3:12 PM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 31, 2024 | Time not confirmed | — | -0.00 | — |
| Feb 29, 2024 | Time not confirmed | — | -0.00 | — |
| Nov 30, 2023 | Time not confirmed | — | 0.00 | — |
| Aug 31, 2023 | Time not confirmed | — | -0.00 | — |
| May 31, 2023 | Time not confirmed | — | -0.00 | — |
Pharmala Biotech Holdings Inc., a biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community. It offers its MDMA drug active pharmaceutical ingredients under the LaNeo brand. The company is headquartered in Vancouver, Canada.